Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
Distal muscle weakness is a common and early feature in long-term enzyme-treated classic infantile Pompe patients.
Orphanet J Rare Dis. 2020 Sep 14;15(1):247. doi: 10.1186/s13023-020-01482-w.
Orphanet J Rare Dis. 2020.
PMID: 32928284
Free PMC article.
Effects of higher and more frequent dosing of alglucosidase alfa and immunomodulation on long-term clinical outcome of classic infantile Pompe patients.
Poelman E, van den Dorpel JJA, Hoogeveen-Westerveld M, van den Hout JMP, van der Giessen LJ, van der Beek NAME, Pijnappel WWMP, van der Ploeg AT.
Poelman E, et al. Among authors: van der giessen lj.
J Inherit Metab Dis. 2020 Nov;43(6):1243-1253. doi: 10.1002/jimd.12268. Epub 2020 Jul 13.
J Inherit Metab Dis. 2020.
PMID: 32506446
Free PMC article.
The aim of this study was to compare the long-term outcome of classic infantile Pompe patients treated with 20 mg/kg alglucosidase alfa every other week (eow) to those treated with 40 mg/kg/week, and to study the additional effect of immunomodulation. ...
The aim of this study was to compare the long-term outcome of classic infantile Pompe patients treated with 20 mg/kg alglucosidase al …
Item in Clipboard
A long term follow-up study of the development of hip disease in Mucopolysaccharidosis type VI.
Oussoren E, Bessems JHJM, Pollet V, van der Meijden JC, van der Giessen LJ, Plug I, Devos AS, Ruijter GJG, van der Ploeg AT, Langeveld M.
Oussoren E, et al. Among authors: van der giessen lj.
Mol Genet Metab. 2017 Jul;121(3):241-251. doi: 10.1016/j.ymgme.2017.05.008. Epub 2017 May 19.
Mol Genet Metab. 2017.
PMID: 28552677
Item in Clipboard
Cite
Cite